Supporting Information
Supporting Information File 1: Additional experimental and analytical data, and NMR spectra of synthesized compounds. | ||
Format: PDF | Size: 3.3 MB | Download |
Cite the Following Article
(Phenylamino)pyrimidine-1,2,3-triazole derivatives as analogs of imatinib: searching for novel compounds against chronic myeloid leukemia
Luiz Claudio Ferreira Pimentel, Lucas Villas Boas Hoelz, Henayle Fernandes Canzian, Frederico Silva Castelo Branco, Andressa Paula de Oliveira, Vinicius Rangel Campos, Floriano Paes Silva Júnior, Rafael Ferreira Dantas, Jackson Antônio Lamounier Camargos Resende, Anna Claudia Cunha, Nubia Boechat and Mônica Macedo Bastos
Beilstein J. Org. Chem. 2021, 17, 2260–2269.
https://doi.org/10.3762/bjoc.17.144
How to Cite
Pimentel, L. C. F.; Hoelz, L. V. B.; Canzian, H. F.; Branco, F. S. C.; de Oliveira, A. P.; Campos, V. R.; Júnior, F. P. S.; Dantas, R. F.; Resende, J. A. L. C.; Cunha, A. C.; Boechat, N.; Bastos, M. M. Beilstein J. Org. Chem. 2021, 17, 2260–2269. doi:10.3762/bjoc.17.144
Download Citation
Citation data can be downloaded as file using the "Download" button or used for copy/paste from the text window
below.
Citation data in RIS format can be imported by all major citation management software, including EndNote,
ProCite, RefWorks, and Zotero.
Presentation Graphic
Picture with graphical abstract, title and authors for social media postings and presentations. | ||
Format: PNG | Size: 10.8 MB | Download |
Citations to This Article
Up to 20 of the most recent references are displayed here.
Scholarly Works
- Santos, C.; Pimentel, L.; Canzian, H.; Oliveira, A.; Junior, F.; Dantas, R.; Hoelz, L.; Marinho, D.; Cunha, A.; Bastos, M.; Boechat, N. Hybrids of Imatinib with Quinoline: Synthesis, Antimyeloproliferative Activity Evaluation, and Molecular Docking. Pharmaceuticals (Basel, Switzerland) 2022, 15, 309. doi:10.3390/ph15030309
- Oliveira, A.; Moura, S.; Pimentel, L.; Neto, J.; Dantas, R.; Silva-Jr, F.; Bastos, M.; Boechat, N. New Imatinib Derivatives with Antiproliferative Activity against A549 and K562 Cancer Cells. Molecules (Basel, Switzerland) 2022, 27, 750. doi:10.3390/molecules27030750